Top

Published in:

01-02-2010 | Original Paper

Injecting Equipment Sharing in Russian Drug Injecting Dyads

Authors: V. Anna Gyarmathy, Nan Li, Karin E. Tobin, Irving F. Hoffman, Nikolai Sokolov, Julia Levchenko, Julia Batluk, Andrei A. Kozlov, Andrei P. Kozlov, Carl A. Latkin

Published in: AIDS and Behavior | Issue 1/2010

Abstract

In this study, we investigated how individual attributes, dyad characteristics and social network characteristics may influence engaging in receptive syringe sharing, distributive syringe sharing and sharing cookers in injecting partnerships of IDUs in St Petersburg, Russia. We found that all three levels were associated with injecting equipment sharing, and that dyad characteristics were modified by characteristics of the social network. Self-reported HIV discordance and male gender concordance played a role in the risk of equipment sharing. Dyad interventions may not be sufficient to reduce injecting risk in IDU partnerships, but a combination of dyad and network interventions that target both IDU partnerships and the entire IDU population may be more appropriate to address injecting risk among IDUs.

Amirkhanian, Y. A., Kelly, J. A., Kirsanova, A. V., DiFranceisco, W., Khoursine, R. A., Semenov, A. V., et al. (2006). HIV risk behaviour patterns, predictors, and sexually transmitted disease prevalence in the social networks of young men who have sex with men in St Petersburg, Russia. International Journal of STD and AIDS, 17, 50–56. doi:10.1258/095646206775220504.CrossRefPubMed

Costenbader, E. C., Astone, N. M., & Latkin, C. A. (2006). The dynamics of injection drug users’ personal networks and HIV risk behaviors. Addiction (Abingdon, England), 101, 1003–1013. doi:10.1111/j.1360-0443.2006.01431.x.

Cox, J., De, P., Morissette, C., Tremblay, C., Stephenson, R., Allard, R., et al. (2008). Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Social Science and Medicine, 66, 211–220. doi:10.1016/j.socscimed.2007.08.022.CrossRefPubMed

De, P., Cox, J., Boivin, J. F., Platt, R. W., & Jolly, A. M. (2007). The importance of social networks in their association to drug equipment sharing among injection drug users: A review. Addiction (Abingdon, England), 102, 1730–1739. doi:10.1111/j.1360-0443.2007.01936.x.

Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., et al. (2004). “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Syndromes, 35, 158–166. doi:10.1097/00126334-200402010-00010.CrossRefPubMed

Desenclos, J. C., Papaevangelou, G., & Ancelle-Park, R. (1993). Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European community study group on HIV in injecting drug users. AIDS (London, England), 7, 1371–1377. doi:10.1097/00002030-199310000-00011.

European Centre for the Epidemiological Monitoring of AIDS (2007). HIV/AIDS surveillance in Europe, end year report 2006. 73, Saint Maurice: Institute de Veille Sanitaire.

Evans, J. L., Hahn, J. A., Page-Shafer, K., Lum, P. J., Stein, E. S., Davidson, P. J., et al. (2003). Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health, 80, 137–146. doi:10.1093/jurban/jtg137.CrossRefPubMed

Friedman, S. R., Curtis, R., Neaigus, A., Jose, B., & Des Jarlais, D. C. (1999). Social networks, drug injectors’ lives, and HIV. New York: Plenum.

Friedman, S. R., Kippax, S. C., Phaswana-Mafuya, N., Rossi, D., & Newman, C. E. (2006). Emerging future issues in HIV/AIDS social research. AIDS (London, England), 20, 959–965.

Granovetter, M. (1983). The strength of weak ties: A network theory revisited. Sociological Theory, 1, 201–233. doi:10.2307/202051.CrossRef

Gyarmathy, V. A., & Latkin, C. A. (2008). Individual and social factors associated with participation in treatment programs for drug users. Substance Use and Misuse, 43, 1865–1881. doi:10.1080/10826080802293038.CrossRefPubMed

Gyarmathy, V. A., & Neaigus, A. (2005). Marginalized and socially integrated groups of IDUs in Hungary: Potential bridges of HIV infection. Journal of Urban Health, 82, iv101–iv112. doi:10.1093/jurban/jti112.PubMed

Gyarmathy, V. A., & Neaigus, A. (2006). The effect of personal network exposure on injecting equipment sharing among Hungarian IDUs. Connections, 15, 29–42.

Gyarmathy, V. A., & Neaigus, A. (2007). The relationship of sexual dyad and personal network characteristics and individual attributes to unprotected sex among young injecting drug users. AIDS and Behavior. doi:10.1007/s10461-007-9285-9.

Gyarmathy, V. A., Neaigus, A., Ujhelyi, E., Szabó, T., & Rácz, J. (2006). Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors. Drug and Alcohol Dependence, 82, S65–S69. doi:10.1016/S0376-8716(06)80011-6.CrossRefPubMed

Gyarmathy, V., Li, N., Tobin, K., Hoffman, I., Sokolov, N., Levchenko, J., et al. (2009). Correlates of unsafe injecting among injecting drug users in St Petersburg, Russia. European Addiction Research, (in press).

Hamers, F. F., & Downs, A. M. (2003). HIV in central and eastern Europe. Lancet, 361, 1035–1044. doi:10.1016/S0140-6736(03)12831-0.CrossRefPubMed

Heimer, R., Barbour, R., Shaboltas, A. V., Hoffman, I. F., & Kozlov, A. P. (2008). Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: Implications for HIV transmission. AIDS (London, England), 22, 123–130.

Kenny, D. A., Kashy, D. A., & Cook, W. (2006). Dyadic data analysis. New York, NY: The Guilford Press.

Kozlov, A. P., Shaboltas, A. V., Toussova, O. V., Verevochkin, S. V., Masse, B. R., Perdue, T., et al. (2006). HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS (London, England), 20, 901–906. doi:10.1097/01.aids.0000218555.36661.9c.

Lambert, E., Normand, J., Stall, R., Aral, S., & Vlahov, D. (2005). Introduction: New dynamics of HIV risk among drug-using men who have sex with men. Journal of Urban Health, 82, i1–i8. doi:10.1093/jurban/jti018.PubMed

Latkin, C., & Knowlton, A. R. (2005). Social network approaches to HIV prevention: Implications to community impact and sustainability. Trickett, E. J. & Pequegnat, W. (Eds.), (pp. 105–129). New York: Oxford University Press.

Latkin, C. A., Mandell, W., Knowlton, A. R., Vlahov, D., & Hawkins, W. (1998). Personal network correlates and predictors of homelessness for injection drug users in Baltimore, Maryland. Journal of Social Distress and the Homeless, 7, 263–278. doi:10.1023/A:1022943311679.CrossRef

Latkin, C., Mandell, W., Oziemkowska, M., Vlahov, D., & Celentano, D. (1994). The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sexually Transmitted Diseases, 21, 161–167. doi:10.1097/00007435-199405000-00006.CrossRefPubMed

Latkin, C., Mandell, W., Vlahov, D., Oziemkowska, M., & Celentano, D. (1996). People and places: Behavioral settings and personal network characteristics as correlates of needle sharing. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, 273–280.PubMed

Liang, K. Y., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73, 13–22. doi:10.1093/biomet/73.1.13.CrossRef

Magis-Rodriguez, C., Brouwer, K. C., Morales, S., Gayet, C., Lozada, R., Ortiz-Mondragon, R., et al. (2005). HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-US border city of Tijuana. Journal of Psychoactive Drugs, 37, 333–339.PubMed

Neaigus, A. (1998). The network approach and interventions to prevent HIV among injection drug users. Public Health Reports, 113, 140–150.PubMed

Neaigus, A., Friedman, S. R., Goldstein, M. F., Ildefonso, G., Curtis, R., & Jose, B. (1995). Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Research Monograph, 151, 20–37.PubMed

Neaigus, A., Gyarmathy, V. A., Miller, M., Frajzyngier, V. M., Friedman, S. R., & Des Jarlais, D. C. (2006). Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndromes, 41, 493–503. doi:10.1097/01.qai.0000186391.49205.3b.CrossRefPubMed

Perngmark, P., Vanichseni, S., & Celentano, D. D. (2008). The Thai HIV/AIDS epidemic at 15 years: Sustained needle sharing among southern Thai drug injectors. Drug and Alcohol Dependence, 92, 183–190. doi:10.1016/j.drugalcdep.2007.07.014.CrossRefPubMed

Rhodes, T., Platt, L., Maximova, S., Latishevskaya, N., Hickman, M., Renton, A., et al. (2006). Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: A multi-city study. Addiction (Abingdon, England), 101, 252–266. doi:10.1111/j.1360-0443.2006.01317.x.

Rhodes, T., Stimson, G. V., Crofts, N., Ball, A., Dehne, K., & Khodakevich, L. (1999). Drug injecting, rapid HIV spread, and the ‘risk environment’: Implications for assessment and response. AIDS, 13(suppl. A), S259–S269.PubMed

Rogers, E. M. (2003). Diffusion of innovations (5th ed.). New York, NY: Free Press.

Sarang, A., Rhodes, T., & Platt, L. (2008). Access to syringes in three Russian cities: Implications for syringe distribution and coverage. International Journal of Drug Policy, 19(suppl. 1), S25–S36.CrossRefPubMed

Schlumberger, M. G., Desenclos, J. C., Papaevangelou, G., Richardson, S. C., & Ancelle-Park, R. (1999). Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: Second study. European community study group on HIV in injecting drug users. European Journal of Epidemiology, 15, 207–215. doi:10.1023/A:1007578402083.CrossRefPubMed

Shearer, J., Johnston, J., Fry, C. L., Kaye, S., Dillon, P., Dietze, P., et al. (2007). Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia. Drug and Alcohol Review, 26, 537–543. doi:10.1080/09595230701499159.CrossRefPubMed

Sherman, S. G., & Latkin, C. A. (2002). Drug users’ involvement in the drug economy: Implications for harm reduction and HIV prevention programs. Journal of Urban Health, 79, 266–277. doi:10.1093/jurban/79.2.266.PubMed

Smith, A. M., Grierson, J., Wain, D., Pitts, M., & Pattison, P. (2004). Associations between the sexual behaviour of men who have sex with men and the structure and composition of their social networks. Sexually Transmitted Infections, 80, 455–458. doi:10.1136/sti.2004.010355.CrossRefPubMed

Somach, S. D., Kochkina, E., & Shlyk, E. (2004). Gender assessment for USAID, Russia—USAID Contract #: GEW-I-01-02-00019-00. www.devtechsys.com/publications/gender/assesments/Final%20Report,%20Russia.pdf: DevTech Systems, Inc.

Todd, C. S., Abed, A. M., Scott, P. T., Botros, B. A., Safi, N., Earhart, K. C., et al. (2008). Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan. The American Journal of Drug and Alcohol Abuse, 34, 91–100. doi:10.1080/00952990701764771.CrossRefPubMed

Unger, J. B., Kipke, M. D., De Rosa, C. J., Hyde, J., Ritt-Olson, A., & Montgomery, S. (2006). Needle-sharing among young IV drug users and their social network members: The influence of the injection partner’s characteristics on HIV risk behavior. Addictive Behaviors, 31, 1607–1618. doi:10.1016/j.addbeh.2005.12.007.CrossRefPubMed

Valente, T. W. (1995). Network models of the diffusion of innovations. Cresskill, NJ: Hampton Press.

Valente, T. W., & Vlahov, D. (2001). Selective risk taking among needle exchange participants: Implications for supplemental interventions. American Journal of Public Health, 91, 406–411. doi:10.2105/AJPH.91.3.406.CrossRefPubMed

Title: Injecting Equipment Sharing in Russian Drug Injecting Dyads
Authors: V. Anna Gyarmathy
Nan Li
Karin E. Tobin
Irving F. Hoffman
Nikolai Sokolov
Julia Levchenko
Julia Batluk
Andrei A. Kozlov
Andrei P. Kozlov
Carl A. Latkin
Publication date: 01-02-2010
Publisher: Springer US
Published in: AIDS and Behavior / Issue 1/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-008-9518-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Barking up the Wrong Evidence Tree. Comment on Lurie & Rosenthal, “Concurrent Partnerships as a Driver of the HIV Epidemic in Sub-Saharan Africa? The Evidence is Limited”

Correlates of Anal Intercourse Vary by Partner Type Among Substance-Using Women: Baseline Data from the UNITY Study

Is Sexual Serosorting Occurring Among HIV-Positive Injection Drug Users? Comparison Between Those with HIV-Positive Partners Only, HIV-Negative Partners Only, and Those with any Partners of Unknown Status

Beyond Monogamy: Opportunities to Further Reduce Risk for HIV Infection Among Married Zimbabwean Women with only One Lifetime Partner

The Mathematics of Concurrent Partnerships and HIV: A Commentary on Lurie and Rosenthal, 2009

Targeting HIV Interventions for Adolescent Girls and Young Women in Southern Africa: Use of the PLACE Methodology in Hwange District, Zimbabwe

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials